Disease Information & Support


The Word:


Generic name Idarubicin
Pronunciation eye-dah-ROO-bi-sin
Brand name(s), other common name(s) Idamycin®
Drug type  Antitumor antibiotic
How the drug is given Intravenously (IV)

Idarubicin is FDA approved in combination with other antileukemic drugs to treat people who have acute myeloid leukemia in adults.

Side effects needing medical attention: If idarubicin accidentally seeps out of the vein, it may damage some tissues and cause scarring. Your healthcare provider should be notified right away if you notice redness, pain or swelling at the IV site; irregular heartbeat; chest pain; severe bleeding or unusual bleeding or bruising; shortness of breath; fever; chills; sore throat; sores in mouth and on lips; stomach pains; rash, itching or hives; nausea and vomiting (mild); diarrhea; headache.

Side effects needing medical attention after stopping this medication: Irregular heartbeat; shortness of breath; swelling of feet and legs.


For information on how to manage the costs of drug therapy, please see Financial Matters and Prescription Drug Coverage, or to speak with an Information Specialist, call (800) 955-4572.

last updated on Monday, October 15, 2012